Rituximab or Zevalin - Efficacy Trial of Therapeutic Alternatives (RoZetta)
Status:
Terminated
Trial end date:
2013-03-05
Target enrollment:
Participant gender:
Summary
The purpose of this study is to evaluate the effect of consolidation treatment Zevalin®
versus maintenance treatment with Rituxan® on progression-free survival (PFS) following
response induction with chemotherapy plus rituximab in previously untreated participants with
follicular lymphoma.